En Français • Read Our Blog • Contact • Home
En Français • Read Our Blog • Contact • Home
| Saturday May 3, 2008 – Travel Day HIV Workshop and Reception Trent University (by invitation) |
||
|---|---|---|
8:00-18:00 |
Travel from Pearson Airport to Trent University | |
12:00-18:00 |
Registration and check in at Trent University | |
12:00-13:00 |
Lunch | |
13:00-17:00 |
Closed Workshop – Host Factors in HIV | |
13:00-13:30 |
Welcome and aims of Workshop – Jeremy Carver/Michel Chrétien/Nathaniel Lewis | |
13:30-15:00 |
10 minute synopses of research programs with questions • Anna Vyakarnam (King’s College, UK), “Anti-viral activity of ps20” |
|
15:00-15:30 |
Break | |
15:30-16:30 |
General discussion on funding strategies going forward | |
16:30-17:00 |
Wrap-up: Anna Vyakarnam /Jeremy Carver | |
18:00-22:00 |
Welcoming Reception and Registration for ICAV participants and Invited Guests at the Canoe Museum  Canoe Museum, hosted by Operitel |
|
Sunday May 4, 2008 – ICAV Scientific Symposium |
||
|---|---|---|
07:30-08:00 |
Registration | Continental breakfast |
08:00-08:15 |
Roberta Bondar | Welcome |
08:15-08:45 |
Chair: Jeremy Carver | Introduction |
08:15-08:45 |
Nabil Seidah | The proprotein convertases affect viral infection in a variety of ways |
08:45-12:30 |
Chair: Nabil Seidah | Session one: Host targets for Influenza |
08:45-09:15 |
Anna Vyakarnam | Anti-viral activity of ps20 |
09:15-09:45 |
Eleanor Fish | Influenza and anti-virals: the fight for supremacy |
09:45-10:15 |
Jonathan Wong | Lioposome encapsulated poly-ICLC as a broad spectrum anti-viral |
10:15-10:30 |
Break | |
10:30-11:00 |
Chris Miller | Nitrous oxide treatment for respiratory viral infection |
11:00-11:30 |
John Nicholls | Correlation of the human pathology of emerging viral infections with ex-vivo models |
11:30-12:30 |
Chair: Nabil Seidah | Session Two: Viral targets for influenza |
11:30-12:00 |
Lieve Naesens | The influenza virus polymerase complex as an anti-viral target |
12:00-13:30 |
Lunch | Lunch speaker TBA |
13:30-17:30 |
Chair: Michel Chrétien | Session Three: International perspectives on Influenza |
13:30-14:00 |
Claude P. Muller | Spread and evolution of HPAI H5N1 in poultry, humans and wild-birds in Sub-Saharan Africa |
14:00-14:30 |
Oyekanmi Nash | H5N1 in Nigeria |
14:30-15:00 |
Paul Zhou | Developing lentivirus-like particles-based immunogens and a neutralization assay against avian flu viruses |
15:30-15:30 |
Break | |
15:30-17:30 |
Chair: Michel Chrétien | Session Four: Dengue and other viruses |
15:30-16:00 |
Janis Lazdins | Dengue: An expanding public health problem in need of innovative solutions |
16:00-16:30 |
Bruno Canard | The Flavivirus NS5 as a drug target |
16:30-17:00 |
Sunday A. Omilabu | Lassa virus |
17:00-17:30 |
Albert Osterhaus | Animal models for H5N1 |
19:00 |
Gala Dinner | The Atrium, Gzowski College, hosted by the Greater Peterborough Innovation Cluster |
Monday May 5, 2008 - International Public Health: the Need for Anti-virals |
||
|---|---|---|
08:00-09:00 |
Registration | Continental Breakfast |
08:30-09:00 |
Bonnie Patterson | Welcome to Trent University |
08:45-09:00 |
Dean Del Mastro MP | Greetings |
09:00-11:00 |
Chair: Jeremy Carver | Session One: Pandemic threat |
09:00-10:00 |
Albert Osterhaus | Keynote: Avian influenza |
10:00-10:45 |
Malik Peiris | Evolution and pathogenesis of H5N1 |
10:45-11:00 |
Honorable Hassan Lawal | Nigerian Minister of Health |
11:00-11:30 |
Break | Press conference |
11:30-13:00 |
Chair: Donald Low | Session Two: Anti-virals and vaccines |
11:45-12:15 |
Oyewale Tomori | Pandemic Threats: A view from the locals |
12:15-14:00 |
Lunch Speaker: Peter Singer | Life Sciences: From Lab to Village |
14:00-16:30 |
Chair: Donald Low | Session Three: International Perspective |
14:00-14:45 |
Frank Plummer | Keynote: Host factors providing HIV protection |
14:45-15:30 |
Claude P. Muller | New and Emerging Viruses: group specific anti-virals would be the answer |
15:30-16:00 |
Break | |
16:00-16:30 |
Arlene King | Director General, Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada |
16:30-17:00 |
Jeremy Carver | Closing remarks – Anti-Virals and Public Health |
18:00 |
Departure for Toronto | |
18:00-20:00 |
NIGERIA: Health Minister Hon Hassan Lawal, Oyekanmi Nash, Abdulsalami Nasidi, Oyewale Tomori, Sunday A. Omilabu, Amubieya Ademola Owoade and Olutosin Alaba Awolude UGANDA: Peter Mutuluuza and Juliet Kyobutungyi |
Reception & Round Table on Africa Networking (by invitation) Moderator: Peter Singer |
Tuesday May 6th, 2008 - Industry and Markets: The Influenza Drug Pipeline |
||
|---|---|---|
8:00-8:30 |
Registration | Continental Breakfast |
8:30-9:00 |
Grant Tipler, RBC Royal Bank |
Welcoming Remarks |
9:00-9:30 |
Donald Low, Toronto Medical Laboratories | Session One: Industry & Markets – The Urgent Need for Novel Anti-Virals |
9:30-10:00 |
Wendy Hill, GAP Strategies |
Vaccines and Anti-Virals - The Need and Differences between the Two |
10:00-10:30 |
Eleanor Fish, Toronto General Research Institute |
The Threat of Emerging Viral Pandemics: A Must-do Anti-Viral Strategy |
10:30-11:00 |
Break | |
11:00-12:00 |
Keynote Speaker: Brian McCarthy Merriman Curhan Ford, New York |
Investment Environment Anti-Virals … An Increasingly Healthy Investment |
12:00-12:15 |
John Kelly Board member, TBI |
Introduction of Minister Wilkinson |
12:15-12:45 |
Featured Speaker: Minister John Wilkinson |
Ontario Minister of Research and Innovation |
12:45-13:00 |
Pierre Jeanniot Foundation for Anti-Virals Board Chair |
Thank you to Minister Wilkinson |
13:00-13:30 |
Lunch | |
13:30-14:00 |
Dale Cumming Acton Biotech | Session Two: Industry Pipeline - Anti-Viral Industry Overview of Players and Contenders: The Pipeline and Score Card |
14:00-14:30 |
Michel Bazinet, CEO | REPLICor |
14:30-15:00 |
Eric Stephen | Defense Research and Development Canada |
15:00-15:30 |
Anne Marie Hayes | Medical Manager for Tamilflu, Roche |
15:30-16:30 |
Moderator: Patrick Michaud, ICAV Board Chair |
Session Three: Looking Forward…Are We Prepared? Panel: Perspectives on the impact of anti-Virals on business in the future |
16:30-17:00 |
Jeremy Carver CEO/CSO ICAV | Closing Remarks |
18:00-20:00 |
Reception, in association with BioFinance 2008 | Hockey Hall of Fame, Brookfield Place (formerly BCE Place) 30 Yonge Street, Toronto |
